{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:13:07Z","timestamp":1779203587127,"version":"3.51.4"},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-01987-9","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:57:07Z","timestamp":1779202627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Re: Clarifying comparative claims in digital cognitive assessment: Assessing concurrent validity in a shared cohort"],"prefix":"10.1186","volume":"18","author":[{"given":"Ali","family":"Jannati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Tobyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Pascual-Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"1","key":"1987_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13195-025-01913-5","volume":"17","author":"A Jannati","year":"2025","unstructured":"Jannati A, Thompson K, Toro-Serey C, Gomes-Osman J, Banks RE, Higgins C, et al. Concurrent detection of cognitive impairment and amyloid positivity with a multimodal machine learning-enabled digital cognitive assessment. Alzheimer\u2019s Res Therapy. 2025;17(1):261.","journal-title":"Alzheimer\u2019s Res Therapy"},{"issue":"12","key":"1987_CR2","doi-asserted-by":"publisher","first-page":"e70966","DOI":"10.1002\/alz.70966","volume":"21","author":"LI Thompson","year":"2025","unstructured":"Thompson LI, Gaster B, Hammers DB, Fittipaldi S, Barrett AM, Partrick KA, et al. Acceptable standards for clinic-based digital cognitive assessments: Recommendations from the Global CEO Initiative on Alzheimer\u2019s Disease. Alzheimer\u2019s Dement. 2025;21(12):e70966.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1987_CR3","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s40120-025-00741-x","volume":"14","author":"JE Galvin","year":"2025","unstructured":"Galvin JE, Kleiman MJ, Harris HM, Estes PW. The Cognivue Amyloid Risk Measure (CARM): A novel method to predict the presence of amyloid with Cognivue Clarity. Neurol Therapy. 2025;14:865\u201380.","journal-title":"Neurol Therapy"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01987-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-01987-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01987-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:57:12Z","timestamp":1779202632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-01987-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":3,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1987"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-01987-9","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.J. and S.T. are employees of Linus Health and receive stock options from Linus Health. A.P.-L. is the co-founder and chief medical officer of Linus Health and co-founder of TI Solutions, and serves as a paid member of the scientific advisory boards for Neuroelectrics, TetraNeuron, MedRhythms, Bitbrain, and AscenZion. A.J., S.T., and A.P.-L. are listed as inventors on issued and pending patents on digital biomarkers of cognitive and functional status, amyloid positivity, and machine learning-enabled clinical decision support.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}